The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target ...

The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.